Raffaele Ratta

Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study

Toni K. Choueiri, Laurence Albigès, Philippe Barthélémy et al. · The Lancet · 2024 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study

Giuseppe Procopio, Giulia Apollonio, Francesco Cognetti et al. · European Urology Oncology · 2019 · 54 citations

Medicine, Oncology, Surgery +15

KEYNOTE-921: Phase III Study of Pembrolizumab Plus Docetaxel for Metastatic Castration-Resistant Prostate Cancer

Daniel P. Petrylak, Raffaele Ratta, Rustem Gafanov et al. · Future Oncology · 2021 · 49 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Influenza Vaccine Indication During Therapy with Immune Checkpoint Inhibitors: A Transversal Challenge. The Invidia Study

Melissa Bersanelli, Diana Giannarelli, Paola Castrignanò et al. · Immunotherapy · 2018 · 46 citations · Full text

Medicine, Immunology, Oncology +17

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression

Vera Cappelletti, Elena Verzoni, Raffaele Ratta et al. · International Journal of Molecular Sciences · 2020 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +17